معرفی
Genta Ishikawa, MD, is an Instructor in the Department of Internal Medicine at Yale School of Medicine, specializing in Pulmonary, Critical Care & Sleep Medicine. He is a clinician-scientist dedicated to advancing treatments for interstitial lung diseases, particularly pulmonary fibrosis, and is actively involved in patient care at the Yale Center for Interstitial Lung Diseases.
Education:
- MD, Hokkaido University School of Medicine (2007)
- MPH, Emory University, Rollins School of Public Health (2017)
- Residency, Internal Medicine, Mount Sinai Beth Israel (2017)
- Fellowship, Pulmonary, Critical Care & Sleep Medicine, Mount Sinai Hospital (2020)
- Postdoctoral Fellowship, Yale University (2023)
Research Interests:
Genta Ishikawa's research centers on the neuro-stromal and neuro-innate mechanisms in lung fibrosis. He investigates how nerve-derived noradrenaline interacts with lung fibroblasts and immune cells expressing alpha-1 adrenoreceptors, contributing to fibrotic progression. His work explores mitochondrial DNA signaling via TLR9 and the therapeutic potential of α1-adrenoreceptor antagonism in fibrotic models and patients.
Publications and Research Trends:
His recent publications, appearing in journals like the American Journal of Respiratory and Critical Care Medicine and European Respiratory Journal, highlight a consistent focus on fibrotic signaling pathways involving mitochondrial DNA, TLR9, and neuro-immune crosstalk. His research integrates molecular biology, immunology, and translational models to uncover novel therapeutic targets for pulmonary fibrosis.
Scientific Awards and Honors:
- Parker B. Francis Fellowship Award (2025)
- Yale's Janeway Society (2023)
- Yale Physician-Scientist Development Award (KL-2) (2023)
- Wit Family Distinguished Scholar in Inflammation Science (2023)
- Pulmonary Fibrosis Foundation Scholar Grant (2022)
Advising, Grants, and Collaborations:
While no formal advisees are listed, Dr. Ishikawa collaborates extensively with leading researchers including Dr. Erica L. Herzog, Dr. Naftali Kaminski, and Dr. Maor Sauler. His work is supported by prestigious grants such as the Pulmonary Fibrosis Foundation Scholar Grant and the Yale KL2 award, reflecting strong institutional backing for his physician-scientist trajectory.
Laboratory and Research Team:
Dr. Ishikawa conducts his research within Herzog's Lab at Yale, a leading center for fibrosis and lung immunology research. His work is integral to the Yale Fibrosis Program and the Yale Center for Interstitial Lung Diseases, contributing to a collaborative, interdisciplinary environment focused on understanding and treating chronic lung diseases.
حوزههای پژوهشی